No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating
Inotiv Insider Bought Shares Worth $414,000, According to a Recent SEC Filing
Lake Street Maintains Inotiv(NOTV.US) With Buy Rating, Maintains Target Price $6
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Ascendis Pharma (ASND) and Champions Oncology (CSBR)
Inotiv, Inc. Faces Financial Turmoil: Going Concern Doubts and Debt Pressures
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating, Announces Target Price $10